izpis_h1_title_alt

Sentinel node biopsy for conjunctival melanoma : single centre experience and review of current literature
ID Perić, Barbara (Avtor), ID Leiler, Špela (Avtor), ID Hawlina, Gregor (Avtor), ID Jančar, Boris (Avtor), ID Snoj, Marko (Avtor), ID Perhavec, Andraž (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (538,49 KB)
MD5: 3E6B061CA0F086B66016F67358E6D78D
URLURL - Izvorni URL, za dostop obiščite https://journals.sagepub.com/doi/10.1177/10732748211042116 Povezava se odpre v novem oknu

Izvleček
Purpose: To evaluate the role of sentinel lymph node (SLN) biopsy in patients with conjuctival melanoma (CjM). Study design: Retrospective observational cohort study and literature review. Subjects: Slovenian patients with CjM are included in the study. Methods: Prospectively collected data of CjM patients treated from June 2005 to December 2016 were retrospectively analyzed. Main outcome measures: The numbers of SLN biopsy procedures, positive and false positive SLN, and local and regional relapses have been described together with overall survival. Results: From June 2005 until December 2016, 24 patients with CjM were treated. The median follow-up time was 65.3 months. The mean Breslow thickness was 1.5 mm (sd = 1.8 mm), and ulceration was present in 29% of cases. Altogether, 14/24 (58%) SLN biopsy procedures were performed. SLN was positive in 2/14 (14%) cases. The estimated 5-year overall survival (OS) of the group was 72.5%, with a median survival of 151 months (95% CI 77–224). From January 2013 to January 2020, five (5/140, 3%) authors reported results comparable to our study. Conclusion: Our results confirm that CjM is a rare disease with approximately 14% of positive SLN. At the moment, there are no firm conclusions regarding who would benefit most from SLN biopsy or whether or not CLND should be offered. Data from literature emphasize the need for consistent and uniform staging and future multicentric studies.

Jezik:Angleški jezik
Ključne besede:conjuctival melanoma, sentinel node biopsy, lymphadenectomy, survival
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:8 str.
Številčenje:Vol. 28
PID:20.500.12556/RUL-144175 Povezava se odpre v novem oknu
UDK:617.7
ISSN pri članku:1526-2359
DOI:10.1177/10732748211042116 Povezava se odpre v novem oknu
COBISS.SI-ID:82235907 Povezava se odpre v novem oknu
Datum objave v RUL:02.02.2023
Število ogledov:950
Število prenosov:90
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Cancer control
Skrajšan naslov:Cancer control
Založnik:SAGE, Moffitt Cancer Center
ISSN:1526-2359
COBISS.SI-ID:523832601 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:konjuktivni melanom, biopsija, limfadenektomija, preživetje, očesne bolezni

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj